{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T09:13:51Z","timestamp":1764494031407},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00345-018-2427-z","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T09:14:37Z","timestamp":1533114877000},"page":"1973-1980","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma"],"prefix":"10.1007","volume":"36","author":[{"given":"Lorenzo","family":"Marconi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roderick","family":"de Bruijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"van Werkhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Beisland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Fife","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Kauffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boerje","family":"Ljungberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surena","family":"Matin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Sjoberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Staehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant D.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Tanguay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Uzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Bex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"key":"2427_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359\u2013E386","journal-title":"Int J Cancer"},{"key":"2427_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"2427_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/21681805.2013.864698","volume":"48","author":"A Thorstenson","year":"2014","unstructured":"Thorstenson A, Bergman M, Scherman-Plogell AH, Hosseinnia S, Ljungberg B, Adolfsson J et al (2014) Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005\u20132010: a population-based study from the national Swedish kidney cancer register. Scand J Urol 48:231\u2013238","journal-title":"Scand J Urol"},{"key":"2427_CR4","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","volume":"67","author":"B Ljungberg","year":"2015","unstructured":"Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913\u2013924","journal-title":"Eur Urol"},{"key":"2427_CR5","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMoa003013","volume":"345","author":"RC Flanigan","year":"2001","unstructured":"Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC et al (2001) Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345:1655\u20131659","journal-title":"N Engl J Med"},{"key":"2427_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0140-6736(01)06103-7","volume":"358","author":"GH Mickisch","year":"2001","unstructured":"Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R, European Organisation for R et al (2001) Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358:966\u2013970","journal-title":"Lancet"},{"key":"2427_CR7","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/01.ju.0000110610.61545.ae","volume":"171","author":"RC Flanigan","year":"2004","unstructured":"Flanigan RC, Mickisch G, Sylvester R, Tangen C, Van Poppel H, Crawford ED (2004) Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 171:1071\u20131076","journal-title":"J Urol"},{"key":"2427_CR8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.eururo.2016.07.005","volume":"70","author":"A Bex","year":"2016","unstructured":"Bex A, Ljungberg B, van Poppel H, Powles T, European Association of U (2016) The role of cytoreductive nephrectomy: European Association of Urology Recommendations in 2016. Eur Urol 70:901\u2013905","journal-title":"Eur Urol"},{"key":"2427_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.eururo.2010.08.029","volume":"58","author":"A Bex","year":"2010","unstructured":"Bex A, Jonasch E, Kirkali Z, Mejean A, Mulders P, Oudard S et al (2010) Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials. Eur Urol 58:819\u2013828","journal-title":"Eur Urol"},{"key":"2427_CR10","doi-asserted-by":"publisher","unstructured":"Mejean A, Ravaud A, Thezenas S, Colas S, Beauval JB, Bensalah K et al (2018) Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. N Engl J Med. \n                    https:\/\/doi.org\/10.1056\/nejmoa1803675","DOI":"10.1056\/nejmoa1803675"},{"key":"2427_CR11","doi-asserted-by":"publisher","first-page":"v605","DOI":"10.1093\/annonc\/mdx440.030","volume":"28","author":"A Bex","year":"2017","unstructured":"Bex A, Mulders P, Jewett M, Wagstaff J, van Velthoven R, Laguna Pes P et al (2017) LBA35Immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib (EORTC 30073 SURTIME). Ann Oncol 28:v605\u2013v649","journal-title":"Ann Oncol"},{"key":"2427_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.eururo.2016.10.029","volume":"71","author":"GD Stewart","year":"2017","unstructured":"Stewart GD, Aitchison M, Bex A, Larkin J, Lawless C, Mejean A et al (2017) Cytoreductive nephrectomy in the tyrosine kinase inhibitor era: a question that may never be answered. Eur Urol 71:845\u2013847","journal-title":"Eur Urol"},{"key":"2427_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1464-410X.2009.09079.x","volume":"106","author":"A Kutikov","year":"2010","unstructured":"Kutikov A, Uzzo RG, Caraway A, Reese CT, Egleston BL, Chen DY et al (2010) Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy. BJU Int 106:218\u2013223","journal-title":"BJU Int"},{"key":"2427_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1586\/era.12.54","volume":"12","author":"A Bex","year":"2012","unstructured":"Bex A, Powles T (2012) Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when. Expert Rev Anticancer Ther 12:787\u2013797","journal-title":"Expert Rev Anticancer Ther"},{"key":"2427_CR15","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/S0022-5347(01)64097-7","volume":"158","author":"ML Fallick","year":"1997","unstructured":"Fallick ML, McDermott DF, LaRock D, Long JP, Atkins MB (1997) Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma. J Urol 158:1691\u20131695","journal-title":"J Urol"},{"key":"2427_CR16","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1002\/cncr.25046","volume":"116","author":"SH Culp","year":"2010","unstructured":"Culp SH, Tannir NM, Abel EJ, Margulis V, Tamboli P, Matin SF et al (2010) Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? Cancer 116:3378\u20133388","journal-title":"Cancer"},{"key":"2427_CR17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.eururo.2012.11.040","volume":"63","author":"V Margulis","year":"2013","unstructured":"Margulis V, Shariat SF, Rapoport Y, Rink M, Sjoberg DD, Tannir NM et al (2013) Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Eur Urol 63:947\u2013952","journal-title":"Eur Urol"},{"key":"2427_CR18","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1016\/S1470-2045(14)70235-9","volume":"15","author":"S Dabestani","year":"2014","unstructured":"Dabestani S, Marconi L, Hofmann F, Stewart F, Lam TB, Canfield SE et al (2014) Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol 15:e549\u2013e561","journal-title":"Lancet Oncol"},{"key":"2427_CR19","doi-asserted-by":"publisher","first-page":"b605","DOI":"10.1136\/bmj.b605","volume":"338","author":"DG Altman","year":"2009","unstructured":"Altman DG, Vergouwe Y, Royston P, Moons KG (2009) Prognosis and prognostic research: validating a prognostic model. BMJ 338:b605","journal-title":"BMJ"},{"key":"2427_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56:337\u2013344","journal-title":"Biometrics"},{"key":"2427_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak 26:565\u2013574","journal-title":"Med Decis Mak"},{"issue":"35","key":"2427_CR22","first-page":"e1","volume":"35","author":"BJ Manley","year":"2017","unstructured":"Manley BJ, Tennenbaum DM, Vertosick EA, Hsieh JJ, Sjoberg DD, Assel M et al (2017) The difficulty in selecting patients for cytoreductive nephrectomy: an evaluation of previously described predictive models. Urol Oncol 35(35):e1\u2013e5","journal-title":"Urol Oncol"},{"key":"2427_CR23","doi-asserted-by":"publisher","unstructured":"Motzer RJ, Russo P (2018) Cytoreductive Nephrectomy\u2014patient selection is key. N Engl J Med. \n                    https:\/\/doi.org\/10.1056\/NEJMe1806331","DOI":"10.1056\/NEJMe1806331"},{"key":"2427_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.eururo.2011.06.041","volume":"60","author":"M Sun","year":"2011","unstructured":"Sun M, Shariat SF, Cheng C, Ficarra V, Murai M, Oudard S et al (2011) Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol 60:644\u2013661","journal-title":"Eur Urol"},{"key":"2427_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1470-2045(12)70559-4","volume":"14","author":"DY Heng","year":"2013","unstructured":"Heng DY, Xie W, Regan MM, Harshman LC, Bjarnason GA, Vaishampayan UN et al (2013) External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol 14:141\u2013148","journal-title":"Lancet Oncol"},{"key":"2427_CR26","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1200\/JCO.1999.17.8.2530","volume":"17","author":"RJ Motzer","year":"1999","unstructured":"Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17:2530\u20132540","journal-title":"J Clin Oncol"},{"key":"2427_CR27","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","volume":"27","author":"DY Heng","year":"2009","unstructured":"Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C et al (2009) Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J Clin Oncol 27:5794\u20135799","journal-title":"J Clin Oncol"},{"key":"2427_CR28","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.eururo.2014.05.034","volume":"66","author":"DY Heng","year":"2014","unstructured":"Heng DY, Wells JC, Rini BI, Beuselinck B, Lee JL, Knox JJ et al (2014) Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 66:704\u2013710","journal-title":"Eur Urol"},{"key":"2427_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/cncr.22827","volume":"110","author":"TK Choueiri","year":"2007","unstructured":"Choueiri TK, Garcia JA, Elson P, Khasawneh M, Usman S, Golshayan AR et al (2007) Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. Cancer 110:543\u2013550","journal-title":"Cancer"},{"key":"2427_CR30","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/annonc\/mdf257","volume":"13","author":"S Negrier","year":"2002","unstructured":"Negrier S, Escudier B, Gomez F, Douillard JY, Ravaud A, Chevreau C et al (2002) Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d\u2019Immunotherapie. Ann Oncol 13:1460\u20131468","journal-title":"Ann Oncol"},{"key":"2427_CR31","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1158\/1078-0432.CCR-11-0553","volume":"17","author":"J Manola","year":"2011","unstructured":"Manola J, Royston P, Elson P, McCormack JB, Mazumdar M, Negrier S et al (2011) Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group. Clin Cancer Res 17:5443\u20135450","journal-title":"Clin Cancer Res"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-018-2427-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2427-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2427-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T20:33:51Z","timestamp":1564605231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-018-2427-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2427"],"URL":"https:\/\/doi.org\/10.1007\/s00345-018-2427-z","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}